Trials / Terminated
TerminatedNCT03819543
SURESTEP: Transcranial Direct Current Stimulation in Super Refractory Status Epilepticus
Transcranial Direct Current Stimulation in SUper REfractory STatus EPilepticus (SURESTEP): Pilot Study of a Novel Therapy in a Common Medical Emergency
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 10 (actual)
- Sponsor
- University of Manitoba · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether transcranial direct current stimulation affects super refractory status epilepticus.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Transcranial Direct Current Stimulation | Application of transcranial direct current stimulation via scalp electrodes over presumed epileptogenic focus for 20 minutes at 2.0 mA. |
Timeline
- Start date
- 2019-07-15
- Primary completion
- 2020-11-30
- Completion
- 2021-08-31
- First posted
- 2019-01-28
- Last updated
- 2023-02-16
- Results posted
- 2023-02-16
Locations
1 site across 1 country: Canada
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03819543. Inclusion in this directory is not an endorsement.